Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCB-BO1202 for Liver Fibrosis in HBV Patients with HCC
NCT02289300Phase 2Withdrawn
- Sponsor
- A2 Healthcare Corporation
- Start
- Jan 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DCB-BO1202 in Liver Fibrosis (LF), sponsored by A2 Healthcare Corporation. Planned start Jan 2020; status: withdrawn.
02
Drugs
DCB-BO1202
03
Conditions
Liver Fibrosis (LF)
Beyond the preview
Go deeper on NCT02289300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02289300.